Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report analysing the market for  blood glucose testing and diabetes management.

The publication Blood Glucose Testing and Diabetes Management reports that there has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe.

The 366 page report notes that once thought of as primarily a childhood disease and sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes (the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet) has resulted in skyrocketing rates of diabetes, particularly Type 2 diabetes, among adults across the world.

As such, the global market for blood glucose testing products is undergoing a significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, certain segments of the market, such as home testing devices for diabetes management, will exhibit strong growth.

Furthermore, non-invasive testing now represents a major new area for the application of IVD testing. Additionally, direct access testing – or over-the-counter testing, which allows consumers to order tests themselves without visiting a doctor – has emerged as a strong force in the blood glucose testing segment.

This study reviews all of the generally-accepted clinical analytical methods that are currently in use today for measuring serum or plasma or whole-blood glucose concentrations. Moreover, it examines clinical measurement devices, reagents and supplies as utilised in hospitals, clinics, doctor’s offices and at-home care locations.

Blood Glucose Testing and Diabetes Management

Report Buyer Product ID: TRI00014
Report Buyer Product Category: Pharma and Healthcare